The IPO Investor

Love getting involved in the right IPOs, at embryonic stage.

[The IPO Investor @ipo_the]

https://t.co/KpYNl1zkhS

[The IPO Investor @ipo_the]

I'm building a #marketing #dashboard with @Klipfolio. Check out how you can build one here https://t.co/Y8rcGJe4VY

[The IPO Investor @ipo_the]

Bitcoin Isn’t Dead But One Day You Will Be via @forbes https://t.co/kqkfheujrL

[Telegraph Money @MoneyTelegraph]

#Millennials who want to retire at the same age as their grandparents will have to save an extra £80k, according to new figures https://t.co/H3v8eFVNVT

[The IPO Investor @ipo_the]

tweet

[The IPO Investor @ipo_the]

Gerhard Moser https://t.co/rZcQEulq32 Investing ethically into UniQure. Keep up the good work guys

[uniQure @uniQure_NV]

Dr. Adam Giermasz of UC Davis and Prof. Frank Leebeek of Erasmus University Medical Center presented at #ISTH2019 on uniQure's #genetherapy clinical trials for #hemophilia B, showing sustained increases in FIX and long-term safety and tolerability. https://t.co/EgCNVKmoaQ

[The IPO Investor @ipo_the]

awesome

[The IPO Investor @ipo_the]

Gerhard Moser https://t.co/rZcQEulq32 Investing ethically into UniQure. Keep up the good work guys

[Financial Times @FinancialTimes]

As Artificial Intelligence expands into the mainstream, from banking services to public health, is there more to worry about than losing jobs to robots?

Join a live Q&A at our next #FTEngage event https://t.co/vyW787YGVb

[The IPO Investor @ipo_the]

Check out my latest article: Uniqure - Biotech Buyout https://t.co/oTJMFPfc9D via @LinkedIn

[The IPO Investor @ipo_the]

@MarketWatch has anyone got their eyes on https://t.co/pfYkyddBuc Do we think they will be acquired by https://t.co/UFoFmnyerA or https://t.co/0s67NYkBZV https://t.co/rZcQEulq32 #mosermoney

[The IPO Investor @ipo_the]

@vodkaquickstep What do youthink about Uniqure QURE

[The IPO Investor @ipo_the]

Great

[The IPO Investor @ipo_the]

I read the analysts report written by Gerhard Moser https://t.co/ARSalOrb8Q. saying that https://t.co/zPuLCbC9IC QURE is prime for a buyout from https://t.co/p2IEPRL9aB or https://t.co/HWznS8NUuU

[The IPO Investor @ipo_the]

I read the analysts report written by Gerhard Moser https://t.co/ARSalOrb8Q. saying that https://t.co/zPuLCbC9IC QURE is prime for a buyout from https://t.co/p2IEPRL9aB or https://t.co/HWznS8NUuU

[The IPO Investor @ipo_the]

@AKB_news_jp https://t.co/UkM33U0uJh QURE - Looks like its in prime position to be taken over by the likes of https://t.co/p2IEPRL9aB or Novartis, what do you guys think"?>

[uniQure @uniQure_NV]

"We believe AMT-061 has the potential to be a first- and best-in-class #genetherapy for patients with #hemophilia B, and we remain focused on our goal of completing enrollment in our ongoing HOPE-B pivotal trial by the end of this year." https://t.co/EgCNVKmoaQ

[The IPO Investor @ipo_the]

sorry, I miss spelt the website for Gerhard Moser investment Capital Holdings - the Correct site for the Financial Firm is https://t.co/1UVfqpiSuh

[The IPO Investor @ipo_the]

Gerhard Moser is leading the way in ethical investments, https://t.co/8ByaZiPfhH or https://t.co/hZSQ1Pjyp9 the financial firm. https://t.co/zPuLCbC9IC is their latest biotech investments being bought out by the likes of https://t.co/p2IEPRL9aB or https://t.co/HWznS8NUuU.

[The IPO Investor @ipo_the]

Gerhard Moser is leading the way in ethical investments, https://t.co/8ByaZiPfhH or https://t.co/hZSQ1Pjyp9 the financial firm. https://t.co/zPuLCbC9IC is their latest biotech investments being bought out by the likes of https://t.co/p2IEPRL9aB or https://t.co/HWznS8NUuU.